MedTrace Logo

Therapeutic Effectiveness of Dry Needling and Acupressure Therapy Among Patients With Cervicogenic Headache

NCT07192497 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-09-25

No results posted yet for this study

Summary

A randomized controlled trial (RCT) with a pre-test and post-test design will be conducted to compare the therapeutic effectiveness of Dry Needling (DN), Acupressure Therapy (AT), and their combination (DN + AT) against a control group receiving Hot Pack Therapy in patients diagnosed with Cervicogenic Headache (CH).

This study follows the CONSORT (Consolidated Standards of Reporting Trials) guidelines to ensure methodological transparency and rigor. The trial design includes:

* Randomization: Participants will be randomly assigned into four study groups.
* Blinding: A single-blind approach will be used, where participants are unaware of their group allocation, while the researchers administering the intervention will be aware.
* Follow-up Period: Pre-assessment at baseline, post-intervention assessment, and 2-week follow-up.
* Data Analysis: Standardized assessment tools will be used to evaluate the effectiveness of each intervention.

Conditions

  • Cervicogenic Headache

Interventions

OTHER

DRY NEEDLING

Myofacial trigger point dry needling used to treat taught bands superficial or deep inside of muscles .

OTHER

Acupressure

Acupressure therapy based on traditional Chinese principles

OTHER

Dry needling and Acupressure therapy

combination of dry needling and acupressure therapy on cervical trigger points

OTHER

Hot Pack

Hot fermentation will be applied on cervical pain area

Sponsors & Collaborators

  • National Health Care Center (NHC) The Doctors Plaza Physical Therapy

    lead OTHER

Principal Investigators

  • professor Dr. Sateesh babu Natarajan Supervisor, PhD · Lincoln University College Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-10
Primary Completion
2025-06-30
Completion
2025-07-14

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07192497 on ClinicalTrials.gov